Retrieved from Varughese, M
While traditional research peptides like Semaglutide target only the GLP-1 receptor, and Tirzepatide targets both GLP-1 and GIP, the Retatrutide Peptide introduces the third component: Glucagon
Additionally, GLP-1 agonists slow gastric emptying, which prolongs the sensation of fullness after eating
Evidence from pre/post, quasi-experimental, and some randomized interventions supports the benefits of FIM for food security, nutrition security, diet quality, blood glucose control, hypertension, disease self-management, self-perceived physical and mental health, and health care utilization [222]
Tame Stress Stress can mess with your blood sugar and make you crave comfort food
Other trials of GLP-1 RAs have also not yet provided a clear answer